Showing results (251-260 of 291) with videos related to

Sort By:
Pageof 30
Frontiers in Oncology|February 12, 2021
Trastuzumab Provides a Comparable Prognosis in Patients With HER2-Positive Breast Cancer to Those With HER2-Negative Breast Cancer: <i>Post Hoc</i> Analyses of a Randomized Controlled Trial of Post-Mastectomy Hypofractionated RadiotherapyGuang-Yi Sun, Hao Jing, Shu-Lian Wang, et al.
BMC Cancer|November 7, 2021
POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trialXu-Ran Zhao, Hui Fang, Yu Tang, et al.
Journal of Cancer Research and Clinical Oncology|November 14, 2022
Effects of gross tumor volume and radiation dose on survival and locoregional recurrence in early-stage extranodal NK/T-cell lymphoma treated with intensity-modulated radiation therapyYang-Mei Zhou, Xin Liu, Yong Yang, et al.
Technology in Cancer Research & Treatment|June 14, 2023
Voluntary Deep Inspiration Breath-Hold (VDIBH) Whole-Breast Irradiation Assisted by Optical Surface Monitoring System (OSMS) in Patients With Left-Sided Breast Cancer: A Prospective Phase II StudyJiang-Hu Zhang, Tan-Tan Li, Shi-Rui Qin, et al.
The Lancet. Oncology|February 4, 2019
Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trialShu-Lian Wang, Hui Fang, Yong-Wen Song, et al.
Cancer Letters|March 21, 2024
Disparities in mortality risk after diagnosis of hematological malignancies in 185 countries: A global data analysisJing Yang, Xin Liu, Qiu-Zi Zhong, et al.
International Journal of Radiation Oncology, Biology, Physics|April 4, 2025
Long-Term Prognostic Analysis of Chemoradiation Therapy Versus Chemotherapy after D2 Resection for High-Risk Gastric Cancer: Results From a Prospective Randomized Control StudyXia-Xi Qiao, Huan-Gang Jiang, Yuan Tang, et al.
Cancer Medicine|January 5, 2024
Prediction of 5-year overall survival of diffuse large B-cell lymphoma on the pola-R-CHP regimen based on 2-year event-free survival and progression-free survivalWan-Ru Zhang, Xin Liu, Qiu-Zi Zhong, et al.
Frontiers in Oncology|October 19, 2020
Timing of Chemotherapy and Radiotherapy Following Breast-Conserving Surgery for Early-Stage Breast Cancer: A Retrospective AnalysisSi-Ye Chen, Yu Tang, Shu-Lian Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 7, 2023
Decreased lymphoma-related deaths and improved long-term relative survival with radiotherapy for early-stage diffuse large B-cell lymphoma in the rituximab eraXin Wang, Xin Liu, Qiu-Zi Zhong, et al.
Pageof 30